Chief Executive Officer

SERB Pharmaceuticals Acquires Y-mAbs Therapeutics in $412 Million All-Cash Transaction

SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

Top biotech deals in August 2025

Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand

Director, Strategic Accounts

SERB Pharmaceuticals is a fast-growing specialty pharmaceutical company that provides life-saving medicines for patients facing rare conditions and emergencies. The Director of Strategic Accounts will be responsible for driving access in Integrated Delivery Networks (IDNs), managing relationships with healthcare decision makers, and ensuring system performance against contracts.

Director, Strategic Accounts- Central

Human Resources Business Partner

National Account Director

Strategic Account Manager, IDN, Market Access

Senior Director Market Access and Strategic Accounts

Sign up with Google

Sign in with Google